Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin versus ciprofloxacin + penicillin prophylaxis in neutropenic patients with hematologic malignancies
NL-OMON21952Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2002
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levofloxacin, ciprofloxacin and phenethicillin in bacterial disease (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Microbiologically documented bacterial infections. Started Jan 2002; status: active, not recruiting.
02
Drugs
levofloxacinciprofloxacinphenethicillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON21952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21952.